# Zoledronic Acid in Cystic Fibrosis

> **NCT01702415** · PHASE4 · WITHDRAWN · sponsor: **Papworth Hospital NHS Foundation Trust**

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** Zoledronic acid
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01702415
- **Lead sponsor:** Papworth Hospital NHS Foundation Trust
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-10
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2015-10-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01702415

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01702415, "Zoledronic Acid in Cystic Fibrosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01702415. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*